Skip to content

Dissection of the etiology of myopia and efficacy and safety of an Artisan phakic iris-claw intraocular lens for the correction of high myopia

Dissection of the etiology of myopia and efficacy and safety of an Artisan phakic iris-claw intraocular lens for the correction of high myopia - myopia study, MYST

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON45140
Enrollment
1400
Registered
2009-10-29
Start date
2009-12-07
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

high myopia severe nearsightedness

Interventions

None listed

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Persons aged 18 years or older, high myopic from SE -6D and higher, and persons with SE -1.5 D to +1.5 D.

Exclusion criteria

Exclusion criteria: younger then age 18; refractive error between SE -1.5 D and -5.75 D; or refractive error SE > 1.5 D

Design outcomes

Primary

MeasureTime frame
Primary study parameters: - Single nucleotide polymorphisms (SNPs) or mutations Primary outcome variable: - High myopia present/absent

Secondary

MeasureTime frame
Secondary study parameters: - environmental risk factors such as reading in youth, education, refractive error of parents etc - range of accommodation Secondary outcome variable: - refraction as continuous variable - axial length - cornea curvature, anterior chamber length - complications of myopia such as glaucoma, retinal defects, staphyloma and macular degeneration - safety of phakic Artisan intraocular lenses

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)